Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Same-patient comparison of fosaprepitant and ondansetron for prevention of chemotherapy-induced nausea and vomiting in head and neck cancer
TCTR20210122002Phase 3Completed
- Sponsor
- Chiang Mai University
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosaprepitant, ondansetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chiang Mai University. Started Oct 2015; status: completed.
02
Drugs
fosaprepitantondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20210122002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210122002.